GLAND PHARMA   
                    
                    
                                                         
                                
                                                                 Back to All Ratios 
                                                
                     | 
                        
                        
                        
                        
                    
GLAND PHARMA Last 5 Year Book Value per Share History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Book NAV/Share(Rs) | 555.40 | 529.56 | 483.12 | 434.84 | 359.30 | 
What is the latest Book Value per Share ratio of GLAND PHARMA ?
| Year | Book Value per Share | 
|---|---|
| Mar2025 | 555.40 | 
| Mar2024 | 529.56 | 
| Mar2023 | 483.12 | 
| Mar2022 | 434.84 | 
| Mar2021 | 359.30 | 
How is Book Value per Share of GLAND PHARMA Trending?
| Years | Book Value per Share | % Change | |
|---|---|---|---|
| Mar2025 | 555.4 | 4.88 | |
| Mar2024 | 529.56 | 9.61 | |
| Mar2023 | 483.12 | 11.10 | |
| Mar2022 | 434.84 | 21.02 | |
| Mar2021 | 359.3 | - | |
Other Financial Ratios of GLAND PHARMA
| Operational &  Financial Ratios Earnings Per Share CEPS DPS Tax Rate  | Margin  Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin  | Performance  Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales  | Efficiency  Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days  | Valuation  Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales  | Growth  Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth  | Financial Stability  Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap  | 
Compare Book Value per Share ratio of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹32,501.0 Cr | 3.7% | -0.4% | 18.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹409,626.0 Cr | 1.2% | 4.4% | -9.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,669.0 Cr | 5.8% | 19.2% | 16.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹122,793.0 Cr | 1.4% | 1.8% | 10.8% | Stock Analytics | |
| CIPLA | ₹122,103.0 Cr | -3.7% | -0.2% | 1.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,857.4 Cr | -7.3% | -4% | -6.1% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year | 
| GLAND PHARMA |    3.7%  | 
                            
                     
                     -0.4%  | 
                     
                     18.7%  | 
                    
| SENSEX |    -0.9%  |    
                      
                    
                     4.6%  | 
                     
                     5%  | 
                    
You may also like the below Video Courses